Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Liaoning Cancer Hospital & Institute
Condition: Breast Cancer Females
NCT07657130
Optimal Application Timing of ADC Drugs for Advanced Breast Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.